|Articles|September 1, 2018
- Applied Clinical Trials-09-01-2018
- Volume 27
- Issue 9
Applied Clinical Trials, September 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials September 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Greater Gift's PopUp Star Eventover 7 years ago
Can FDA Put Some Heat Back Under European Adaptive Pathways?over 7 years ago
Next-Generation Clinical Trialsover 7 years ago
Clinical Trials In a Dish: A Revolution Beginsover 7 years ago
EU’s Status on IDMPover 7 years ago
Ensuring High-Quality Data in Complex, In-Home Clinical Trialsover 7 years ago
FDA Promotes Surrogate Endpoints, ‘Seamless’ Clinical Trialsover 7 years ago
Q&A: Clinical Trials Need To Grow In RelevanceNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Neutral Tech Adoption at Sites, Scaling Unstructured Data for eSource, and Novo Nordisk’s CagriSema NDA
5